Skip to main content
Top
Published in: Pediatric Nephrology 8/2010

01-08-2010 | Original Article

Prevalence and clinical correlates of microalbuminuria in children with sickle cell disease

Authors: Lauren J. Becton, Ram V. Kalpatthi, Elizabeth Rackoff, Deborah Disco, John K. Orak, Sherron M. Jackson, Ibrahim F. Shatat

Published in: Pediatric Nephrology | Issue 8/2010

Login to get access

Abstract

Sickle cell disease (SCD) is associated with a large spectrum of renal abnormalities, one of which, microalbuminuria/proteinuria (MA/P), is a known predictor of end-stage renal disease. We studied 90 children with SCD (57% male; mean age 11.4 ± 5.2 years) to determine the prevalence and examine clinical correlates of MA/P. The average of two spot urine microalbumin-to-creatinine samples obtained 6 months apart was recorded. Medical records were reviewed for demographic and biochemical data. Medication use, resting office blood pressures (BP), vaso-occlusive pain crises (VOC), and monthly transfusions were recorded. Fourteen children (15.5%) had MA/P. Hemoglobin (Hb) levels were significantly lower in the children with MA than in those without MA/P (8.8 ± 1.1 vs. 9.8 ± 1.4 g/dL, respectively) and were significantly correlated with MA (rho = 0.24, p = 0.03). Children with MA were more likely to have abnormal BP (p = 0.058), with 5/14 being hypertensive or pre-hypertensive. In a multivariate logistic regression model of MA, both Hb and BP classification remained in the final model. MA is a simple screening biomarker of early kidney injury in children with SCD. Larger studies to evaluate predictive factors of MA and the relationship to BP are needed.
Literature
1.
go back to reference Powars D, Elliott-Mills D, Chan L, Niland J, Hiti A, Opas L, Johnson C (1991) Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality. Ann Intern Med 115:614–620PubMed Powars D, Elliott-Mills D, Chan L, Niland J, Hiti A, Opas L, Johnson C (1991) Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality. Ann Intern Med 115:614–620PubMed
2.
go back to reference Bank N, Kiroycheva M, Ahmed F, Anthony G, Fabry M, Nagel R, Singhal P (1998) Peroxynitrite formation and apoptosis in transgenic sickle cell mouse kidneys. Kidney Int 54:1520–1528CrossRefPubMed Bank N, Kiroycheva M, Ahmed F, Anthony G, Fabry M, Nagel R, Singhal P (1998) Peroxynitrite formation and apoptosis in transgenic sickle cell mouse kidneys. Kidney Int 54:1520–1528CrossRefPubMed
3.
go back to reference Falk R, Scheinman J, Phillips G, Orringer E, Johnson A, Jennette J (1992) Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme. N Engl J Med 326:910–915PubMedCrossRef Falk R, Scheinman J, Phillips G, Orringer E, Johnson A, Jennette J (1992) Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme. N Engl J Med 326:910–915PubMedCrossRef
4.
go back to reference Wesson D (2002) The initiation and progression of sickle cell nephropathy. Kidney Int 61:2277–2286CrossRefPubMed Wesson D (2002) The initiation and progression of sickle cell nephropathy. Kidney Int 61:2277–2286CrossRefPubMed
5.
go back to reference Allon M, Lawson L, Eckman J, Delaney V, Bourke E (1988) Effects of nonsteroidal antiinflammatory drugs on renal function in sickle cell anemia. Kidney Int 34:500–506CrossRefPubMed Allon M, Lawson L, Eckman J, Delaney V, Bourke E (1988) Effects of nonsteroidal antiinflammatory drugs on renal function in sickle cell anemia. Kidney Int 34:500–506CrossRefPubMed
6.
7.
go back to reference Statius van Eps L, Schouten H, Haar Romeny-Wachter C, La Porte-Wijsman L (1970) The relationship between age and renal concentrating capacity in sickle cell disease and hemoglobin C disease. Clin Chim Acta 27:501–511CrossRefPubMed Statius van Eps L, Schouten H, Haar Romeny-Wachter C, La Porte-Wijsman L (1970) The relationship between age and renal concentrating capacity in sickle cell disease and hemoglobin C disease. Clin Chim Acta 27:501–511CrossRefPubMed
8.
go back to reference Goossens J, Statius van Eps L, Schouten H, Giterson A (1972) Incomplete renal tubular acidosis in sickle cell disease. Clin Chim Acta 41:149–156CrossRefPubMed Goossens J, Statius van Eps L, Schouten H, Giterson A (1972) Incomplete renal tubular acidosis in sickle cell disease. Clin Chim Acta 41:149–156CrossRefPubMed
9.
go back to reference DeFronzo R, Taufield P, Black H, McPhedran P, Cooke C (1979) Impaired renal tubular potassium secretion in sickle cell disease. Ann Intern Med 90:310–316PubMed DeFronzo R, Taufield P, Black H, McPhedran P, Cooke C (1979) Impaired renal tubular potassium secretion in sickle cell disease. Ann Intern Med 90:310–316PubMed
10.
go back to reference Powars D, Chan L, Hiti A, Ramicone E, Johnson C (2005) Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients. Medicine 84:363–376CrossRefPubMed Powars D, Chan L, Hiti A, Ramicone E, Johnson C (2005) Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients. Medicine 84:363–376CrossRefPubMed
11.
go back to reference Alvarez O, Lopez-Mitnik G, Zilleruelo G (2008) Short-term follow-up of patients with sickle cell disease and albuminuria. Pediatr Blood Cancer 50:1236–1239CrossRefPubMed Alvarez O, Lopez-Mitnik G, Zilleruelo G (2008) Short-term follow-up of patients with sickle cell disease and albuminuria. Pediatr Blood Cancer 50:1236–1239CrossRefPubMed
12.
go back to reference McKie K, Hanevold C, Hernandez C, Waller J, Ortiz L, McKie K (2007) Prevalence, prevention and treatment of microalbuminuria and proteinuria in children with sickle cell disease. J Pediatr Hematol Oncol 29:140–144CrossRefPubMed McKie K, Hanevold C, Hernandez C, Waller J, Ortiz L, McKie K (2007) Prevalence, prevention and treatment of microalbuminuria and proteinuria in children with sickle cell disease. J Pediatr Hematol Oncol 29:140–144CrossRefPubMed
13.
go back to reference Datta V, Ayengar J, Karpate S, Chaturvedi P (2003) Microalbuminuria as a predictor of early glomerular injury in children with sickle cell disease. Indian J Pediatr 70:307–309CrossRefPubMed Datta V, Ayengar J, Karpate S, Chaturvedi P (2003) Microalbuminuria as a predictor of early glomerular injury in children with sickle cell disease. Indian J Pediatr 70:307–309CrossRefPubMed
14.
go back to reference Dharnidharka V, Dabbagh S, Atiyeh B, Simpson P, Sarnaik S (1998) Prevalence of microalbuminuria in children with sickle cell disease. Pediatr Nephrol 12:475–478CrossRefPubMed Dharnidharka V, Dabbagh S, Atiyeh B, Simpson P, Sarnaik S (1998) Prevalence of microalbuminuria in children with sickle cell disease. Pediatr Nephrol 12:475–478CrossRefPubMed
15.
go back to reference McBurney P, Hanevold C, Hernandez C, Waller J, McKie K (2002) Risk factors for microalbuminuria in children with sickle cell anemia. J Pediatr Hematol Oncol 24:473–477CrossRefPubMed McBurney P, Hanevold C, Hernandez C, Waller J, McKie K (2002) Risk factors for microalbuminuria in children with sickle cell anemia. J Pediatr Hematol Oncol 24:473–477CrossRefPubMed
16.
go back to reference Marsenic O, Couloures K, Wiley J (2008) Proteinuria in children with sickle cell disease. Nephol Dial Transplant 23:715–720CrossRef Marsenic O, Couloures K, Wiley J (2008) Proteinuria in children with sickle cell disease. Nephol Dial Transplant 23:715–720CrossRef
17.
go back to reference Alvarez O, Montane B, Lopez G, Wilkinson J, Miller T (2006) Early blood transfusions protect against microalbuminuria in children with sickle cell disease. Pediatr Blood Cancer 47:71–76CrossRefPubMed Alvarez O, Montane B, Lopez G, Wilkinson J, Miller T (2006) Early blood transfusions protect against microalbuminuria in children with sickle cell disease. Pediatr Blood Cancer 47:71–76CrossRefPubMed
18.
go back to reference National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114:555–576CrossRef National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114:555–576CrossRef
19.
go back to reference Hankins J, Jeng M, Harris S, Li C, Liu T, Wang W (2005) Chronic transfusion therapy for children with sickle cell disease and recurrent acute chest syndrome. J Pediatr Hematol Oncol 27:158–161CrossRefPubMed Hankins J, Jeng M, Harris S, Li C, Liu T, Wang W (2005) Chronic transfusion therapy for children with sickle cell disease and recurrent acute chest syndrome. J Pediatr Hematol Oncol 27:158–161CrossRefPubMed
21.
go back to reference Wigfall D, Ware R, Burchinal M, Kinney T, Foreman J (2000) Prevalence and clinical correlates of glomerulopathy in children with sickle cell disease. J Pediatr 136:749–753CrossRefPubMed Wigfall D, Ware R, Burchinal M, Kinney T, Foreman J (2000) Prevalence and clinical correlates of glomerulopathy in children with sickle cell disease. J Pediatr 136:749–753CrossRefPubMed
22.
go back to reference Aoki R, Saad S (1990) Microalbuminuria in sickle cell disease. Braz J Med Biol Res 23:1103–1106PubMed Aoki R, Saad S (1990) Microalbuminuria in sickle cell disease. Braz J Med Biol Res 23:1103–1106PubMed
23.
go back to reference Guasch A, Navarrete J, Nass K, Zayas C (2006) Glomerular involvement in adults with sickle cell hemoglobinopathies: prevalence and clinical correlates of progressive renal failure. J Am Soc Nephrol 17:2228–2235CrossRefPubMed Guasch A, Navarrete J, Nass K, Zayas C (2006) Glomerular involvement in adults with sickle cell hemoglobinopathies: prevalence and clinical correlates of progressive renal failure. J Am Soc Nephrol 17:2228–2235CrossRefPubMed
24.
go back to reference Voskaridou E, Terpos E, Michail S, Hantzi E, Anagnostopoulos A, Margeli A, Simirloglou D, Loukopoulos D, Papassotiriou I (2006) Early markers of renal dysfunction in patients with sickle cell/B-thalessemia. Kidney Int 69:2037–2042CrossRefPubMed Voskaridou E, Terpos E, Michail S, Hantzi E, Anagnostopoulos A, Margeli A, Simirloglou D, Loukopoulos D, Papassotiriou I (2006) Early markers of renal dysfunction in patients with sickle cell/B-thalessemia. Kidney Int 69:2037–2042CrossRefPubMed
25.
go back to reference Kinney T, Helms R, O’Branski E, Ohene-Frempong K, Wang W, Daeschner C, Vichinsky E, Redding-Lallinger R, Gee B, Platt O, Ware R (1999) Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I/II trial. Blood 94:1550–1554PubMed Kinney T, Helms R, O’Branski E, Ohene-Frempong K, Wang W, Daeschner C, Vichinsky E, Redding-Lallinger R, Gee B, Platt O, Ware R (1999) Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I/II trial. Blood 94:1550–1554PubMed
26.
go back to reference Fitzhugh C, Wigfall D, Ware R (2005) Enalapril and hydroxyurea therapy for children with sickle cell nephropathy. Pediatr Blood Cancer 45:982–985CrossRefPubMed Fitzhugh C, Wigfall D, Ware R (2005) Enalapril and hydroxyurea therapy for children with sickle cell nephropathy. Pediatr Blood Cancer 45:982–985CrossRefPubMed
Metadata
Title
Prevalence and clinical correlates of microalbuminuria in children with sickle cell disease
Authors
Lauren J. Becton
Ram V. Kalpatthi
Elizabeth Rackoff
Deborah Disco
John K. Orak
Sherron M. Jackson
Ibrahim F. Shatat
Publication date
01-08-2010
Publisher
Springer-Verlag
Published in
Pediatric Nephrology / Issue 8/2010
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-010-1536-8

Other articles of this Issue 8/2010

Pediatric Nephrology 8/2010 Go to the issue